CAR T‐cell therapy for pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR T‐cell therapy for pancreatic cancer

Published:2017-03-27 Issue:1 Volume:116 Page:63-74
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

DeSelm Carl J.¹,Tano Zachary E.²,Varghese Anna M.³,Adusumilli Prasad S.¹²^ORCID

Affiliation:

1. Center for Cell EngineeringMemorial Sloan Kettering Cancer CenterNew YorkNew York

2. Thoracic ServiceDepartment of SurgeryMemorial Sloan Kettering Cancer CenterNew YorkNew York

3. Gastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineMemorial Sloan Kettering Cancer CenterNew YorkNew York

Funder

Memorial Sloan-Kettering Cancer Center

Stand Up To Cancer

National Cancer Institute

Congressionally Directed Medical Research Programs

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.24627

Reference146 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

3. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

4. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

5. Role of immune cells in pancreatic cancer from bench to clinical application

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

2. Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions;Current Oncology;2024-09-04

3. Potential Use of Human Mesenchymal Stem Cells (hMSCs) in Pancreatic Damage/Cancer;OBM Genetics;2024-07-17

4. Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice;Journal of Gastrointestinal Oncology;2024-02

5. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target;Frontiers in Immunology;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3